Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome

Christelle Chemaga Nkonpawa,1 Vicky Jocelyne Ama Moor,1,2 Aurel T Tankeu,3 Audrey Synthia Momo,1 Guy Sadeu Wafeu,4 Falmata Amazia,2 Jan Rene Nkeck,2,5 Tasha Manases,6 Julius Dohbit Sama,7 Simeon Pierre Choukem6,8,9 1Department of Biochemistry, Faculty of Medicine and Biomedical Sciences, University...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chemaga Nkonpawa C, Ama Moor VJ, Tankeu AT, Momo AS, Wafeu GS, Amazia F, Nkeck JR, Manases T, Dohbit Sama J, Choukem SP
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	interleukin 6 high sensitivity c reactive protein polycystic ovary syndrome insulin resistance sub-saharan africa Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/07a58e861a3c4e0f9e346d3df8505306
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:07a58e861a3c4e0f9e346d3df8505306
record_format	dspace
spelling	oai:doaj.org-article:07a58e861a3c4e0f9e346d3df85053062021-12-02T17:21:54ZInflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome1178-7031https://doaj.org/article/07a58e861a3c4e0f9e346d3df85053062021-09-01T00:00:00Zhttps://www.dovepress.com/inflammation-and-insulin-resistance-in-a-group-of-sub-saharan-african--peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Christelle Chemaga Nkonpawa,1 Vicky Jocelyne Ama Moor,1,2 Aurel T Tankeu,3 Audrey Synthia Momo,1 Guy Sadeu Wafeu,4 Falmata Amazia,2 Jan Rene Nkeck,2,5 Tasha Manases,6 Julius Dohbit Sama,7 Simeon Pierre Choukem6,8,9 1Department of Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 2Laboratory of Biochemistry, University Teaching Hospital, Yaoundé, Cameroon; 3Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; 4Centre for Research on Filariasis and Other Tropical Diseases, Yaoundé, Cameroon; 5Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 6Health and Human Development Research Network, Douala, Cameroon; 7Department of Obstetrics and Gynecology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 8Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; 9Department of Internal Medicine and Specialties, Douala General Hospital, Douala, CameroonCorrespondence: Aurel T Tankeu Route d’Oron 77, Lausanne, 1010, SwitzerlandTel +4176 772 3001Email aurelnet2014@yahoo.comBackground: Studies report high levels of inflammatory markers in women with polycystic ovary syndrome (PCOS), reflecting chronic low-grade inflammation. This inflammation is thought to be associated with insulin resistance. We aim to evaluate inflammatory markers [high sensitivity C reactive protein (CRP) and interleukin 6] and insulin resistance in women with PCOS in Yaoundé, Cameroon.Methods: We conducted a comparative cross-sectional study including 32 women with PCOS aged between 18 and 44 years and 32 controls matched for age and body mass index (BMI). Homeostasis model assessment of insulin resistance (HOMA-IR) index calculated using C peptide levels was used to evaluate insulin resistance. Serum levels of high sensitivity CRP (hsCRP) and interleukin 6 (IL-6) were measured. Comparisons were made using the Student’s T-test and non-parametric tests (Mann–Whitney U-test, Kruskal–Wallis test).Results: We found that the median [25th– 75th percentile] level of hsCRP was significantly higher in women with PCOS compared to the controls (0.63 [0.32– 3.81] mg/L vs. 0.47 [0.15– 1.04] mg/L; p=0.01), while IL-6 levels were not different (8.61 [4.1– 33.79] pg/mL for PCOS vs. 8.80 [5.28– 38.85] pg/mL for controls; p=0.51). We noted that women with PCOS had a higher HOMA-IR index (1.15± 0.90 vs. 0.77± 0.38; p=0.03). However, there was no correlation between hsCRP level and the HOMA-IR index (Spearman correlation coefficient=0.10; p=0.62).Conclusion: PCOS is associated with an increased level of hsCRP and insulin resistance in Cameroonian women. This exploratory study provides baseline evidence for larger-scale studies.Keywords: interleukin 6, high sensitivity C reactive protein, polycystic ovary syndrome, insulin resistance, sub-Saharan AfricaChemaga Nkonpawa CAma Moor VJTankeu ATMomo ASWafeu GSAmazia FNkeck JRManases TDohbit Sama JChoukem SPDove Medical Pressarticleinterleukin 6high sensitivity c reactive proteinpolycystic ovary syndromeinsulin resistancesub-saharan africaPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 4643-4649 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	interleukin 6 high sensitivity c reactive protein polycystic ovary syndrome insulin resistance sub-saharan africa Pathology RB1-214 Therapeutics. Pharmacology RM1-950
spellingShingle	interleukin 6 high sensitivity c reactive protein polycystic ovary syndrome insulin resistance sub-saharan africa Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Chemaga Nkonpawa C Ama Moor VJ Tankeu AT Momo AS Wafeu GS Amazia F Nkeck JR Manases T Dohbit Sama J Choukem SP Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome
description	Christelle Chemaga Nkonpawa,1 Vicky Jocelyne Ama Moor,1,2 Aurel T Tankeu,3 Audrey Synthia Momo,1 Guy Sadeu Wafeu,4 Falmata Amazia,2 Jan Rene Nkeck,2,5 Tasha Manases,6 Julius Dohbit Sama,7 Simeon Pierre Choukem6,8,9 1Department of Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 2Laboratory of Biochemistry, University Teaching Hospital, Yaoundé, Cameroon; 3Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland; 4Centre for Research on Filariasis and Other Tropical Diseases, Yaoundé, Cameroon; 5Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 6Health and Human Development Research Network, Douala, Cameroon; 7Department of Obstetrics and Gynecology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon; 8Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; 9Department of Internal Medicine and Specialties, Douala General Hospital, Douala, CameroonCorrespondence: Aurel T Tankeu Route d’Oron 77, Lausanne, 1010, SwitzerlandTel +4176 772 3001Email aurelnet2014@yahoo.comBackground: Studies report high levels of inflammatory markers in women with polycystic ovary syndrome (PCOS), reflecting chronic low-grade inflammation. This inflammation is thought to be associated with insulin resistance. We aim to evaluate inflammatory markers [high sensitivity C reactive protein (CRP) and interleukin 6] and insulin resistance in women with PCOS in Yaoundé, Cameroon.Methods: We conducted a comparative cross-sectional study including 32 women with PCOS aged between 18 and 44 years and 32 controls matched for age and body mass index (BMI). Homeostasis model assessment of insulin resistance (HOMA-IR) index calculated using C peptide levels was used to evaluate insulin resistance. Serum levels of high sensitivity CRP (hsCRP) and interleukin 6 (IL-6) were measured. Comparisons were made using the Student’s T-test and non-parametric tests (Mann–Whitney U-test, Kruskal–Wallis test).Results: We found that the median [25th– 75th percentile] level of hsCRP was significantly higher in women with PCOS compared to the controls (0.63 [0.32– 3.81] mg/L vs. 0.47 [0.15– 1.04] mg/L; p=0.01), while IL-6 levels were not different (8.61 [4.1– 33.79] pg/mL for PCOS vs. 8.80 [5.28– 38.85] pg/mL for controls; p=0.51). We noted that women with PCOS had a higher HOMA-IR index (1.15± 0.90 vs. 0.77± 0.38; p=0.03). However, there was no correlation between hsCRP level and the HOMA-IR index (Spearman correlation coefficient=0.10; p=0.62).Conclusion: PCOS is associated with an increased level of hsCRP and insulin resistance in Cameroonian women. This exploratory study provides baseline evidence for larger-scale studies.Keywords: interleukin 6, high sensitivity C reactive protein, polycystic ovary syndrome, insulin resistance, sub-Saharan Africa
format	article
author	Chemaga Nkonpawa C Ama Moor VJ Tankeu AT Momo AS Wafeu GS Amazia F Nkeck JR Manases T Dohbit Sama J Choukem SP
author_facet	Chemaga Nkonpawa C Ama Moor VJ Tankeu AT Momo AS Wafeu GS Amazia F Nkeck JR Manases T Dohbit Sama J Choukem SP
author_sort	Chemaga Nkonpawa C
title	Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome
title_short	Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome
title_full	Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome
title_fullStr	Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome
title_full_unstemmed	Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome
title_sort	inflammation and insulin resistance in a group of sub-saharan african women with polycystic ovary syndrome
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/07a58e861a3c4e0f9e346d3df8505306
work_keys_str_mv	AT chemagankonpawac inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT amamoorvj inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT tankeuat inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT momoas inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT wafeugs inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT amaziaf inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT nkeckjr inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT manasest inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT dohbitsamaj inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome AT choukemsp inflammationandinsulinresistanceinagroupofsubsaharanafricanwomenwithpolycysticovarysyndrome
_version_	1718381008125952000

Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome

Ejemplares similares